EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Personalizing immunosuppressive therapy: predictors of drug switches in Malaysian kidney transplant recipients

Chiau Ling Choong, Farida Islahudin, Mohd Makmor-Bakry, Nor Asyikin Mohd Tahir, Hin-Seng Wong, Rosnawati Yahya

Journal of Pharmacy & Pharmaceutical Sciences · 2025

DOI: 10.3389/jpps.2025.14632 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Pharmacy & Pharmaceutical Sciences, 2025. Verfasst von Chiau Ling Choong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center of Quality Medicine Management, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia. Hauptthemen laut MEDLINE: Drug Substitution, Immunosuppressive Agents, Kidney Transplantation. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Tacrolimus-mycophenolic acid (MPA)-prednisolone immunosuppression remains the first-line management of kidney transplantation. Despite this, a switch to low-dose tacrolimus in combination with an mTOR inhibitor may be inevitable in some patients due to various factors. This study aims to identify the reasons and factors influencing the switch of tacrolimus-MPA to other combination immunosuppressive agents among kidney transplant recipients (KTRs).

Methods

This retrospective observational cohort study included adult KTRs between year 2011–2019 at the two main kidney transplant centers in Malaysia. Demographic data, clinical, laboratory and medication information were collected. Multiple logistic regression was used to determine factors associated with the initial switch of tacrolimus-MPA immunosuppressive therapy.

Results

From the 257 KTRs studied, 81 KTRs had their immunosuppressive agents switched from tacrolimus-MPA-prednisolone immunosuppressive regimen, with majority (96.3%, n = 78) switching to everolimus, an mTOR inhibitor in combination with low-dose tacrolimus. The average time switch was 125.8 ± 100.9 days. The main reasons for the initial switch include unresolved transaminitis (n = 15, 18.5%), cytomegalovirus (CMV) infection (n = 13, 16.0%) and BK virus (BKV) infection (n = 10, 12.3%). In the multiple logistic analysis, Malay ethnicity (P < 0.001), KTRs without post-transplant hypertension (P = 0.004) and KTRs with BKV infection (P < 0.001) were predictors for the initial switch of tacrolimus-MPA-prednisolone immunosuppressive therapy.

Conclusion

Early identification of factors associated with the switch may prepare healthcare professionals for KTRs risk stratification, allowing ample time for appropriate optimization of tacrolimus-MPA-prednisolone immunosuppressive therapy based on individual patient’s needs. This can possibly be a cost-effective alternative to switching to mTOR inhibitors for improved transplant outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug SubstitutionImmunosuppressive AgentsKidney TransplantationAdultFemaleHumansMaleMiddle AgedCohort StudiesEverolimusMalaysiaMycophenolic AcidPrecision MedicinePrednisoloneRetrospective StudiesTacrolimusTransplant Recipients

Stichwörter der Autor:innen

everolimusimmunosuppression switchimmunosuppressive agentskidney transplantationtacrolimus

Substanzen

EverolimusImmunosuppressive AgentsMycophenolic AcidPrednisoloneTacrolimus

Autor:innen und Institutionen

  • Center of Quality Medicine Management, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
  • Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia.
  • Department of Nephrology, Selayang Hospital, Ministry of Health Malaysia, Batu Caves, Malaysia.
  • Sunway Medical Centre, Department of Nephrology, Subang Jaya, Malaysia.
  • Department of Nephrology, Kuala Lumpur Hospital, Ministry of Health Malaysia, Kuala Lumpur, Malaysia.

Zitieren

APA

Choong, C. L., Islahudin, F., Makmor-Bakry, M., Mohd Tahir, N. A., Wong, H. S., & Yahya, R. (2025). Personalizing immunosuppressive therapy: predictors of drug switches in Malaysian kidney transplant recipients. Journal of Pharmacy & Pharmaceutical Sciences. https://doi.org/10.3389/jpps.2025.14632

Vancouver

Choong CL, Islahudin F, Makmor-Bakry M, Mohd Tahir NA, Wong HS, Yahya R. Personalizing immunosuppressive therapy: predictors of drug switches in Malaysian kidney transplant recipients. Journal of Pharmacy & Pharmaceutical Sciences. 2025. doi:10.3389/jpps.2025.14632

BibTeX
@article{Choong2025,
  author = {Choong, Chiau Ling and Islahudin, Farida and Makmor-Bakry, Mohd and Mohd Tahir, Nor Asyikin and Wong, Hin-Seng and Yahya, Rosnawati},
  title = {Personalizing immunosuppressive therapy: predictors of drug switches in Malaysian kidney transplant recipients},
  journal = {Journal of Pharmacy & Pharmaceutical Sciences},
  year = {2025},
  doi = {10.3389/jpps.2025.14632}
}
Kostenlos starten →